Career Level: E

Be part of history in the making. AstraZeneca is building its first‑ever biologics manufacturing campus in Singapore—a USD 1.5 billion, innovative hub that unites end‑to‑end Antibody–Drug Conjugate (ADC) capabilities under one roof: small‑molecule chemical API production, large‑molecule antibody manufacturing, conjugation, and fill‑and‑finish (including sterile filling and lyophilization). Powered by sophisticated digitalization, automation, and artificial intelligence for autonomous manufacturing—and targeting carbon neutrality—this next‑generation site will set a new benchmark for environmentally responsible biologics production.

Are you ready to turn data, cognitive technologies, and robotic processes into measurable business outcomes that help deliver life‑changing medicines? Do you thrive at the intersection of discovery and delivery—shaping ideas into production solutions that improve quality, safety,...